Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03867084
Brief Title: Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

First Submitted : March 6, 2019
First Submitted that Met QC Criteria : March 6, 2019
First Posted : March 7, 2019

Last Update Submitted that Met QC Criteria : September 23, 2021
Last Update Posted : September 24, 2021